Evidence map›Paper›PMID 33735523›Full record

ArticleCurrent protocols2021

Real-Time Assessment of Mitochondrial Toxicity in HepG2 Cells Using the Seahorse Extracellular Flux Analyzer.

Jether Amos Espinosa, Grace Pohan, Michelle R Arkin, Sarine Markossian

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Current protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Dysregulation of Mitochondrial Function in Cancer Cells.International journal of molecular sciences · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Common methods in mitochondrial research (Review).International journal of molecular medicine · 2022
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Jether Amos EspinosaSmall Molecule Discovery Center and Department of Pharmaceutical Chemistry, University of California, San Francisco, California.
Grace PohanSmall Molecule Discovery Center and Department of Pharmaceutical Chemistry, University of California, San Francisco, California.
Michelle R ArkinSmall Molecule Discovery Center and Department of Pharmaceutical Chemistry, University of California, San Francisco, California.
Sarine MarkossianSmall Molecule Discovery Center and Department of Pharmaceutical Chemistry, University of California, San Francisco, California.
University of California, San Francisco · USDiscovery Centre · CA

Funding

Protein and small-molecule tools to probe the conformational dependence of the VCP/p97 protein-protein interaction network--Equipment SupplementR01GM130145 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ARKIN, MICHELLE · 2018 to 2021
$1.6M
NIGMS NIH HHS R01GM130145NIH HHS
6 · The paper itself

Abstract

The liver is the primary organ responsible for drug detoxification. Drug-induced liver injury (DILI) is a leading cause of attrition during drug development and is one of the main reasons that drugs are withdrawn from the market. Hence, the prevention of DILI plays a central role in the overall drug-discovery process. Most of the liver's energy supply comes in the form of adenosine triphosphate (ATP), which is largely generated by mitochondria. This article describes the evaluation of drug-induced mitochondrial dysfunction using the Seahorse Extracellular Flux Analyzer (Agilent). The described protocols detail the accurate measurement of ATP production rate in HepG2 cells after exposure to a panel of potentially toxic compounds. This assay measures changes in extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) as indicators of glycolysis and mitochondrial respiration-the two major energy-generating pathways in a cell. This assay provides a useful model to predict mitochondrial dysfunction-mediated DILI. © 2021 Wiley Periodicals LLC. Basic Protocol: Measurement of cellular ECAR, OCR, and ATP production in live HepG2 cells Support Protocol 1: Culturing and maintaining of HepG2 cells Support Protocol 2: Determining optimal cell density per well.

Indexed as

SmegmamorphaAnimalsGlycolysisHep G2 CellsMitochondriaOxygen ConsumptionATP productiondrug-induced liver injury (DILI)ECARglycolysisHepG2mitochondrial respirationOCRoxidative phosphorylationPERSeahorse

Identifiers

PMID33735523
OpenAlexW3137177646

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.